Skip to content
knowrare
HealthSignal
Your condition community

Living with Hemochromatosis type 3

An inherited condition where too much iron builds up in the body, especially the liver, heart, and pancreas.

Understanding Hemochromatosis type 3

Hemochromatosis type 3 is an inherited condition in which too much iron builds up in the body, called iron overload.

Extra iron can harm organs, especially the liver, heart, and pancreas. Early symptoms can include tiredness, weakness, and joint pain. Later problems may include liver disease, diabetes, and heart problems. It usually starts in the teen years or adulthood. Doctors may use blood tests, MRI, or a liver biopsy, and genetic testing can confirm it.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Patchy darker skin (hyperpigmentation)
  • Tiredness and weakness
  • Joint pain
  • Belly pain
  • Loss of sex drive
  • Diabetes or heart problems

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include digestive system specialists and genetic specialists.

  3. Consider genetic testing

    Changes in TFR2 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

Care & treatment

Care team
Digestive system specialists (gastroenterologists); Genetic specialists (geneticists)
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with rare disease patient organizations for support
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Could genetic testing for the TFR2 gene confirm my diagnosis?
Should my liver, heart, and blood sugar be checked regularly?
Should my brothers and sisters be tested?

Quick facts

Symptoms usually startTeenager and as an Adult
InheritanceAutosomal Recessive
GenesTFR2

It is caused by changes in the TFR2 gene. It is autosomal recessive, so a child inherits a changed copy of the gene from each parent.

GeneticGastrointestinalInherited Metabolic

Also known as: hemochromatosis due to defect in transferrin receptor 2; hereditary hemochromatosis caused by mutation in tfr2; hereditary hemochromatosis type 3; hfe3; tfr2 (transferrin receptor 2 gene) related hemochromatosis; tfr2 hereditary hemochromatosis

Patient organizations

Rare-disease groups that can help

Source: NIH GARD · Hemochromatosis type 3GARD ID 10093 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Hemochromatosis type 3.

Explore the Hemochromatosis type 3 blog

Explore research for Hemochromatosis type 3

Explore actively recruiting Hemochromatosis type 3 studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Hemochromatosis type 3 with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Hemochromatosis type 3 studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Hemochromatosis type 3

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Hemochromatosis type 3

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Hemochromatosis type 3 experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.